Rapid AMR Testing in the Fight Against Tuberculosis
EU Innovation Council and SMEs Executive Agency via YouTube
Power BI Fundamentals - Create visualizations and dashboards from scratch
Google AI Professional Certificate - Learn AI Skills That Get You Hired
Overview
Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Explore a groundbreaking innovation in health and biotechnology that significantly reduces antibiotic resistance testing time for tuberculosis in this 20-minute podcast episode. Delve into the radical advancement developed by EMPE Diagnostics, which received joint funding from the European Innovation Council (EIC) and the Bill & Melinda Gates Foundation. Listen as Iordanis Arzimanoglou, EIC programme manager for health and biotechnology and medical molecular geneticist, and Pavan Asalapuram, co-founder and Vice-CEO of EMPE Diagnostics, discuss the development, commercialization, and scaling up of this crucial technology. Gain insights into the challenges of treating tuberculosis, particularly in Eastern Europe, and learn how this innovation contributes to the fight against antimicrobial resistance. Discover the role of EUeic support and the collaborative efforts driving progress in rapid AMR testing for tuberculosis.
Syllabus
Intro
What is EUeic
Statistics on TB
TB in Eastern Europe
Challenges in treating TB
Discussion
EUeic support
Bill and Melinda Gates Foundation
Taught by
EU Innovation Council and SMEs Executive Agency